Tisa-cel in patients with primary CNS lymphoma

Evaluating longitudinal consolidation patterns in patients with primary CNS lymphomaПодробнее

The importance of circulating tumor DNA in patients with primary CNS lymphomaПодробнее

Insights into the diagnosis of primary CNS lymphoma and challenges in this spaceПодробнее

Analyzing patterns of disease failure in patients with primary CNS lymphomaПодробнее

Efficacy & toxicity of CAR-T therapy in patients with secondary CNS involvementПодробнее

The role of CAR-T therapy in primary and secondary CNS lymphomaПодробнее

The current SoC for patients with primary CNS lymphomaПодробнее

Primary CNS Lymphoma An Overview of Management & Highlight of Advances - Joe Mendez, M.D.Подробнее

Primary Central Nervous System LymphomaПодробнее

Progression-free survival milestones in primary central nervous system lymphomaПодробнее

CD19 CAR-T for CNS lymphomaПодробнее

Real world data for axi-cel in lymphoma with secondary CNS involvementПодробнее

Update in primary CNS lymphoma managementПодробнее

Outcomes of older patients with primary CNS lymphomaПодробнее

Primary CNS lymphomaПодробнее

TAP funded Tier study for relapsed and refractory CNS lymphoma patientsПодробнее

What's new in the approach to primary CNS lymphoma: Upfront and relapsedПодробнее

The need to improve management and treatment strategies for secondary CNS lymphomaПодробнее

Thiotepa-containing regimens for PCNSL patients undergoing autoHCTПодробнее